a client with end-stage cancer has been on extended-release morphine sulfate (ms contin) for bone cancer. the client has significant respiration depression, which is suspected to be caused by an added dose of medication. narcan is administered to the client. what would the health care practitioner expect regarding the use of this narcotic antagonist?